Food Or Edible As Carrier For Pharmaceutical Patents (Class 424/439)
-
Patent number: 9491961Abstract: A method of preparing a salt product comprises the steps of: (i) providing a mixture which comprises salt dissolved in a solvent, said mixture further containing an organic material that is solid under ambient temperature conditions; and (ii) atomizing said mixture and evaporating said solvent to produce a salt product comprised of particles of salt incorporating said organic material. The organic material may be a polymer such as a carbohydrate (e.g. maltodextrin or Gum Arabic). Novel salt products are disclosed which comprise hollow particles having a shell formed for individual crystallites of salt. The salt product is useful as a seasoning for food and may be used in lower amounts than conventional salt to provide the same taste. Particular advantages are obtained in the baking of bread.Type: GrantFiled: April 3, 2013Date of Patent: November 15, 2016Assignee: EMINATE LIMITEDInventors: Stephen John Minter, Sarah Maude
-
Patent number: 9463224Abstract: Methods and compositions are provided for increasing responsiveness to therapeutic metalloproteases including increasing and/or maximizing responsiveness and preventing botulinum and tetanus toxin resistance due to a functional deficiency of zinc. Also provided are methods for zinc replacement or supplement in lacking individuals comprising the administration of a zinc supplement for a loading period and/or administration of a phytase supplement together with the zinc supplement. Also provided are methods for standardization of botulinum toxin potency assays that provide for greater certainty and margins of safety in the use of products from different manufacturers.Type: GrantFiled: November 24, 2014Date of Patent: October 11, 2016Assignee: CNSS IP Holdings, Inc.Inventor: Charles N. S. Soparkar
-
Patent number: 9456630Abstract: The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of bifidobacterium longum ATCC BAAA-999.Type: GrantFiled: April 20, 2012Date of Patent: October 4, 2016Assignee: Nestec S.A.Inventors: Annick Mercenier, Stephanie Blum-Sperisen, Florence Rochat
-
Patent number: 9452190Abstract: Methods for the treatment and prevention of neural cell and neuro-pathological disorders are provided, comprising contacting the neural cells, or administering to a subject in need thereof, botanical raw material (BRM) or an extract obtainable from passion fruits. Compositions, as well as a nutraceutical composition comprising the same are also provided.Type: GrantFiled: January 15, 2015Date of Patent: September 27, 2016Assignees: THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANISATION (ARO) (VOLCANI CENTER), YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.Inventors: Alon Samach, Oren Tirosh, Edna Pesis, Avital Artan, Livnat Goldenberg, Aron Troen
-
Patent number: 9445621Abstract: The present invention relates to (fruit) juices and nectars formulations, comprising (LC)-PUFA's, which do not have the characteristic fish taste of the (long chain) polyunsaturated fatty acids. Furthermore, the present invention also relates to a base material, which comprises PUFA and ?-carotene and the use of such a base material to produce a (fruit) juice or (fruit) nectar formulation.Type: GrantFiled: September 3, 2010Date of Patent: September 20, 2016Assignee: DSM IP ASSETS B.V.Inventors: Simone Koenig-Grillo, Neil MacFarlane, Thomas Lindemann, Karl Manfred Voelker
-
Patent number: 9446086Abstract: A novel herbal extract, MF101, is effective in the treatment of symptoms of menopause.Type: GrantFiled: November 28, 2011Date of Patent: September 20, 2016Assignee: BIONOVO, INC.Inventor: Isaac Cohen
-
Patent number: 9433235Abstract: Described is a solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides in aqueous liquids, wherein the solubilization agent consists of a mixture of: (a) one emulsifying polymer or a mixture of two, three or more emulsifying polymers, (b) one saponin or a mixture of two, three or more saponins, (c) one partially or fully water-miscible, preferably liquid, solvent or a mixture of partially or fully water-miscible, preferably liquid, solvents, preferably selected from the group consisting of ethanol, propylene glycol (1,2-propanediol), glycerin, triacetin (glycerin triacetate), diacetin (glycerin diacetate) and triethyl citrate, and (d) water. The solubilization agent is particularly suitable for sparingly water soluble polyphenols, flavonoids and/or diterpenoid glucosides. The invention also relates to compositions and (food or cosmetic) formulations comprising said solubilization agent.Type: GrantFiled: January 24, 2011Date of Patent: September 6, 2016Assignee: SYMRISE AGInventors: Dirk Schrader, Thomas Riess, Cornelia Homner, Christopher Sabater-Lüntzel
-
Patent number: 9431283Abstract: A system and method manipulate micro objects. A field generator is configured to generate a force field varying in both space and time to manipulate the micro objects on a substrate. The substrate is not permanently affixed to the field generator and allows the force field to pass through the substrate.Type: GrantFiled: September 19, 2013Date of Patent: August 30, 2016Assignee: Palo Alto Research Center IncorporatedInventors: Jason Thompson, Eugene M. Chow, JengPing Lu, Gregory L. Whiting, David K. Biegelsen, Janos Veres
-
Patent number: 9416160Abstract: A bacterial macromolecular complex produced by bacteria belonging to the Bifidobacterium longum strain deposited according to the treaty of Budapest under number CNCM I-3994 with the Collection Nationale de Cultures de Microorganismes (CNCM) [National Collection of Microorganism Cultures], consisting of chains combining a lipoprotein and an oligosaccharide, wherein: the lipoprotein has a molecular weight of from 30 kDa to 60 kDa; the oligosaccharide has a molecular weight of less than 15 kDa, and preferably less than 10 kDa; the lipoprotein component, which consists of all the lipoproteins of each of the chains, represents from 75 to 99%, preferentially from 80 to 98%, more preferentially from 85 to 95% by weight of the total weight of the complex, and the oligosaccharide component, which consists of all the oligosaccharides combined with each of the chains, represents from 1 to 25%.Type: GrantFiled: July 5, 2011Date of Patent: August 16, 2016Assignee: BIFINOVEInventors: Jean-Pierre Blareau, Michel Colavizza, Frederic Huguet, Charles Romond
-
Patent number: 9386790Abstract: A method of alleviating symptoms of, or treating, pancreatic beta-cell damage in a subject includes a step of identifying a subject having pancreatic beta-cell damage. Multiple cycles of a diet protocol are administered to the subject. The diet protocol includes administering of a fasting mimicking diet and a re-feeding diet where the fasting mimicking diet is provided for a first time period and the re-feeding diet is provided for a second time period.Type: GrantFiled: July 1, 2014Date of Patent: July 12, 2016Assignee: University of Southern CaliforniaInventors: Valter D. Longo, Chia-Wei Cheng
-
Patent number: 9375461Abstract: The present invention relates to a composition comprising a combination of at least one proteolytic enzyme, such as subtilisin, and at least one lipolytic enzyme, for use in preventing triglyceride synthesis, advantageously by degrading 2-monoacylglycerol in the intestine. The invention also has as an object such a composition for use as a drug, cosmetic agent, medical device, dietary composition, dietary supplement or nutraceutical, notably for use in preventing or treating obesity, atherosclerosis, type 2 diabetes or for use in preventing or reducing excess weight.Type: GrantFiled: May 22, 2013Date of Patent: June 28, 2016Assignee: IMARKO RESEARCH S.A.Inventor: Max Rombi
-
Patent number: 9359426Abstract: The present invention relates to methods for producing low-iron Lf having improved antimicrobial activity and to a low-iron Lf having improved antimicrobial activity.Type: GrantFiled: April 23, 2010Date of Patent: June 7, 2016Assignee: WESTLAND CO-OPERATIVE DIARY COMPANY LIMITEDInventors: Kevin Neil Pearce, Shaojiang Chen
-
Patent number: 9326539Abstract: This invention relates to fat containing consumable food products comprising ?-cyclodextrin. The food products have reduced levels of bioavailable fat but have substantially the same fat, cholesterol and caloric content as a like food without ?-cyclodextrin. The invention also relates to methods for reducing the bioavailability of fats in fat containing food products without reducing caloric intake as determined by bomb calorimetry and to methods for increasing high density lipoproteins in a subject and reducing or controlling weight by administering the food products of this invention.Type: GrantFiled: August 30, 2013Date of Patent: May 3, 2016Assignee: Soho Flordis International Pty Ltd.Inventors: Joseph D Artiss, Catherine Jen
-
Patent number: 9308223Abstract: A composition comprising various vitamins to make a multi-vitamin. The vitamins identified in multi-vitamin include vitamin B-1, vitamin B-2, niacinamide, vitamin B-6, vitamin B-12, pantothenic acid, folic acid, beta carotene, iron, biotin, choline, vitamin A, vitamin E and vitamin C. The multi-vitamin soothe pain, depression, weakness and insomnia and works best with variety of food and less dairy products. Lead combined with calcium effects are severe than lead effects only; it elevates blood pressure, cholesterol, glucose, weight and cause frequent infections; bigger than normal dose of antibiotics need in infections; and variation in quantities of vitamins are needed to soothe the symptoms.Type: GrantFiled: July 15, 2013Date of Patent: April 12, 2016Inventor: Renuka Maewal
-
Patent number: 9295656Abstract: The present invention provides a particulate composition wherein an oil component containing reduced coenzyme Q10 is polydispersed forming a domain in a matrix containing a water-soluble excipient, which simultaneously shows high oxidative stability and high oral absorbability, a production method thereof, and a stabilizing method thereof. It also provides a food, food with nutrient function claims, food for specified health uses, dietary supplement, nutritional product, animal drug, drink, feed, pet food, cosmetic, pharmaceutical product, therapeutic drug, prophylactic drug and the like, which contain the composition.Type: GrantFiled: June 22, 2007Date of Patent: March 29, 2016Assignee: KANEKA CORPORATIONInventors: Takashi Ueda, Shinsuke Akao, Shiro Kitamura, Hideyuki Kishida, Takahiro Ueda
-
Patent number: 9295662Abstract: The present disclosure is directed to methods for enhancing, improving or increasing fertility or reproductive function. For example, the present disclosure is directed to a method for enhancing, improving, or increasing a female human's likelihood of becoming pregnant comprising: administering to the human a nutritional, dietary, or food fatty acid supplement comprising: at least 30% docosahexaenoic acid (DHA), by weight of the total fatty acids in the supplement in a form chosen from ethyl ester, free fatty acid, and triglyceride.Type: GrantFiled: March 7, 2013Date of Patent: March 29, 2016Assignees: Children's Medical Center Corporation, The General Hospital CorporationInventors: Mark Puder, Deepika Nehra, Bo R. Rueda
-
Patent number: 9277763Abstract: Several embodiments of the present invention relate generally to the use of non-pathogenic microorganisms to prevent the growth and/or activity of pathogenic microorganisms in food products. More specifically, several embodiments relate to manipulation of the pH of low acid foods by non-pathogenic microorganisms to generate a local environment that is adverse to pathogenic microorganisms.Type: GrantFiled: June 23, 2014Date of Patent: March 8, 2016Assignee: Starbucks CorporationInventors: Lisa L. Beckman, Michael A. Bauman, Curtis R. Moon, Mark B. Satterfield, Marcia K. Walker, Dennis A. Lonergan
-
Patent number: 9278050Abstract: A dissolvable medication administration bag for the safe and effective crushing and administration of medication to patients who have difficulty swallowing pills. A dissolvable medication administration bag may be constructed in accordance with a pill crusher pouch embodiment into which a pill is placed prior to being crushed and subsequently the whole of pouch and the crushed pill contents are dissolved into a liquid, e.g. a beverage, as a means of reducing health hazards associated with current pill crushing practices such as inadvertent direct contact and aerosolization with subsequent inhalation of the crushed medication.Type: GrantFiled: March 31, 2014Date of Patent: March 8, 2016Inventor: Trevor Anderson
-
Patent number: 9271983Abstract: A composition including a plurality of active ingredients. A first active ingredient of the active ingredients is pyruvate. For each other active ingredient, an amount of that active ingredient is proportionally less than an amount of the first active ingredient. The composition can affect ATP and Krebs efficiency when ingested by an animal.Type: GrantFiled: December 18, 2012Date of Patent: March 1, 2016Assignee: BIOADATP, LLCInventor: Kevin Meehan
-
Patent number: 9271942Abstract: A method of producing microcapsules of the type having a core and a coating encapsulating the core comprises the steps of providing a core-forming fluid stream and a coating-forming fluid stream, providing a two spray nozzle arrangement having a core nozzle disposed concentrically about a second nozzle, spraying the core-forming fluid stream from the core nozzle and the coat-forming fluid stream from the concentric nozzle to produce microcapsules, and solidifying the microcapsules upon formation in a suitable gas. Spray drying or spray chilling may be employed as the means of solidifying the microcapsules. Microcapsules having a core and a solid coat are also described.Type: GrantFiled: November 7, 2007Date of Patent: March 1, 2016Assignee: ROYAL COLLEGE OF SURGEONS IN IRELANDInventor: Zebunnissa Ramtoola
-
Patent number: 9259430Abstract: The present invention provides a composition comprising HMB and Vitamin D. Methods of administering HMB and Vitamin D to an animal are also described. Vitamin D and HMB are administered to increase muscle mass, strength, and functionality. The combination of Vitamin D and HMB together has a synergistic effect, which results in a surprising and unexpected level of improvement in muscle mass, strength and functionality.Type: GrantFiled: March 19, 2014Date of Patent: February 16, 2016Assignee: Metabolic Technologies, Inc.Inventors: John Rathmacher, John Fuller, Jr., Shawn Baier, Steve Nissen, Naji Abumrad
-
Patent number: 9238024Abstract: A method of improving health in a canine includes administering to the canine a nutritional supplement comprising an amino acid secretagogue composition, which stimulates the pituitary gland of the canines to produce growth hormone. The nutritional supplement may be administered orally. The nutritional supplement may comprise L-arginine hydrochloride, Oxo-proline, L-lysine hydrochloride, and cysteine. When desired, the nutritional supplement may consist essentially of L-arginine hydrochloride, Oxo-proline, L-lysine hydrochloride, N-acetyl-L-cysteine, L-glutamine, and schizonepeta powder.Type: GrantFiled: June 10, 2014Date of Patent: January 19, 2016Assignee: Quality IP Holdings, LLCInventors: Amy L. Heaton, Mitchell K. Friedlander, Dennis Gay
-
Patent number: 9233090Abstract: The present invention relates to the field of nutrition; in particular to the prevention and/or treatment of malnutrition. One embodiment of the present invention relates to a nutritional composition enriched in cysteine for use in the treatment and/or prevention of malnutrition and disorders related thereto. Such a composition may in particular, but not exclusively, be useful for the elderly population.Type: GrantFiled: October 19, 2011Date of Patent: January 12, 2016Assignee: Nestec S.A.Inventors: Denis Breuille, Isabelle Papet, Karine Vidal
-
Patent number: 9226945Abstract: A nutritional composition comprising a partially hydrolyzed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-? per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed.Type: GrantFiled: February 22, 2013Date of Patent: January 5, 2016Assignee: Nestec S.A.Inventors: Annick Mercenier, Marie-Claire Fichot, Adrian Zuercher
-
Patent number: 9216203Abstract: A natural antibiotic health supplement, having garlic, onion, horseradish root, cayenne or habanero peppers, ginger, organic unfiltered apple cider vinegar, unfiltered raw honey, cinnamon, echinacea, and monolaurin. The natural antibiotic health supplement is effective to support a person's immune system, and especially when it detects various common strains of viruses, bad bacteria, and infections.Type: GrantFiled: April 24, 2013Date of Patent: December 22, 2015Inventor: Franco Gennaro
-
Patent number: 9186356Abstract: Methods for rescuing learning, memory and/or motor function deficits associated with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) are disclosed. The method comprises: a) administering to an animal having FTLD-U a therapeutically effective amount of an autophagy inducer; b) causing a decrease in the amount of ubiquitinated TDP-43 aggregation forms in the brain of the animal; and c) causing an improvement of the learning, memory capacities and/or motor function of the animal.Type: GrantFiled: January 4, 2012Date of Patent: November 17, 2015Assignee: Academia SinicaInventors: Che-Kun James Shen, Kuen-Jer Tsai
-
Patent number: 9179690Abstract: The present invention relates to edible products with masked bitter, sour and/or astringent taste. The new products comprise a sweetening agent and from 0.2 to 25% by weight plant sterol ester, wherein the amount of sweetening agent is reduced as compared to a regular product.Type: GrantFiled: April 22, 2004Date of Patent: November 10, 2015Assignee: RAISIO NUTRITION LTD.Inventors: Anniina Honkanen, Päivi Kuusisto, Ritva Lahtinen, Leena Koponen
-
Patent number: 9155704Abstract: The present invention relates to a more palatable pharmaceutical composition comprising carprofen and at least one flavoring agent, and more particularly pertains to a more palatable and more voluntarily consumed pharmaceutically active dosage of carprofen, made available in the form of an orally administered tablet that is easy to swallow, with the same dissolution profile and bioequivalence of less palatable carprofen compositions, such as those compositions without a flavoring agent, and used for the indication of relieving clinical symptoms of pain and inflammation associated with osteoarthritis and postoperative surgery in mammals, by reduced prostaglandin production via inhibition of cyclooxygenase-2. Also included are analytical methods for in vitro dissolution testing of this unique composition to demonstrate bioequivalence to less palatable non-flavored and chewable compositions.Type: GrantFiled: July 13, 2014Date of Patent: October 13, 2015Inventor: Jugal K. Taneja
-
Patent number: 9149050Abstract: Conjugated linoleic acid (CLA) or a derivative thereof may be used in reducing the rate of increase of fat mass in a growing child.Type: GrantFiled: April 14, 2010Date of Patent: October 6, 2015Assignee: STEPAN SPECIALTY PRODUCTS, LLCInventors: Marianne O'Shea, Chryssanthi Stylianopoulos, Corey Edison Scott, Dale A. Schoeller
-
Patent number: 9149061Abstract: The invention relates to a salt substitute mixture containing NaCl, KCl and sodium gluconate. The ratio by weight of KCl to sodium gluconate ranges from 1.5:1 to 1:1.5 and the proportion of NaCl is at least 45% by weight. Furthermore, the invention relates to the use of the mixture in the food industry and as a spice mixture.Type: GrantFiled: March 17, 2007Date of Patent: October 6, 2015Assignee: JUNGBUNZLAUER LADENBURG GMBHInventors: Matthias Pfeiffer, Claudia Scholten, Sabine Oellers
-
Patent number: 9144248Abstract: The use is described of a compound of Formula (I) As a flavoring or flavoring mixture for imparting, modifying and/or enhancing one, two or all the taste impressions umami, kokumi and salty. Flavoring mixtures, vegetable extracts and preparations according to the invention and associated uses and methods are also described.Type: GrantFiled: May 25, 2012Date of Patent: September 29, 2015Assignee: SYMRISE AGInventors: Jakob Peter Ley, Katharina Reichelt, Susanne Paetz, Michael Backes, Katja Obst
-
Patent number: 9145396Abstract: The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.Type: GrantFiled: November 7, 2013Date of Patent: September 29, 2015Assignee: Targacept, Inc.Inventors: Srinivasa Rao Akireddy, Balwinder Singh Bhatti, Timothy J. Cuthbertson, Gary Maurice Dull, Craig Harrison Miller, Joseph Pike Mitchener, Julio A. Munoz, Pieter Albert Otten
-
Patent number: 9133255Abstract: Controlled studies demonstrate that products and related methods using soy related peptides lower total and LDL cholesterol levels in individuals. In one exemplary embodiment of the present disclosure, a product containing an effective amount of lunasin peptides that lowers cholesterol levels in an individual that consumes the lunasin peptides is provided. In another exemplary embodiment of the present disclosure, a composition containing an effective amount of lunasin peptides or lunasin peptide derivatives and one or more enzyme inhibitors is provided. In a related exemplary embodiment of the present disclosure, a method for lowering or reducing cholesterol levels in an individual is provided where a product containing an effective amount of lunasin peptides to an individual is provided and a claim that the product lowers or reduces cholesterol, total cholesterol, LDL cholesterol or lipid levels in an individual that consumes the composition is made.Type: GrantFiled: October 31, 2013Date of Patent: September 15, 2015Assignee: Soy Labs, LLCInventor: Alfredo Flores Galvez
-
Patent number: 9133176Abstract: Methods for the synthesis, isolation, and purification of procyanidin B2 are disclosed. The synthetic methods utilize epicatechin as a starting material and produce procyanidin B2 in high yields. The isolation methods extract procyanidin B2 from a sample of bark powder from plant matter of the genus Uncaria. The isolated and/or synthesized procyanidin B2 is used to treat amyloid disease, such as Alzheimer's disease and Parkinson's disease as well as improve cognitive performance and increase learning and memory in Alzheimer's patients. Pharmaceutical compositions containing the synthesized and/or isolated procyanidin B2 are also disclosed.Type: GrantFiled: May 12, 2008Date of Patent: September 15, 2015Assignee: PROTEOTECH INC.Inventors: Gerardo Castillo, Beth Nguyen, Paula Choi, Lesley Larsen, Stephen Lorimer, Alan Snow
-
Patent number: 9125926Abstract: Provided are compositions comprising an active ingredient having antispasmodic and/or prokinetic activity, preferably vicenin 2 or biologically active analogs thereof.Type: GrantFiled: November 29, 2012Date of Patent: September 8, 2015Assignee: AMINO UP CHEMICAL CO. LTDInventors: Hajime Fujii, Sybille Buchwald-Werner
-
Patent number: 9084730Abstract: The present invention relates to a solid pharmaceutical composition comprising a solid dispersion containing at least one active principle and a pharmaceutically acceptable polymer matrix, a characterized in that said pharmaceutically acceptable polymer matrix comprises a blend of (i) polydextrose, in the form of a continuous polydextrose phase, in order to promote the disintegration of the composition in an aqueous medium, and (ii) at least one polymer other than polydextrose, in the form of a continuous phase of this polymer, whereby the polydextrose is in a concentration of at least 20 wt % and the at least one polymer other than polydextrose is in a concentration of at least 20 wt % in relation to the total weight of said pharmaceutically acceptable polymer matrix.Type: GrantFiled: March 15, 2007Date of Patent: July 21, 2015Assignee: SANOFIInventors: Michel Bedos, Thierry Breul, Stephen Byard, Isabel Ribeiro Dos Santos
-
Patent number: 9085520Abstract: Disclosed is a chalcone composition for treating diabetes and metabolic syndromes. In particular, the chalcone compound bound with 2-halogen in ring A significantly decreases the blood glucose level in the in vitro anti-diabetic effect experiment. In the in vivo animal model, the leading chalcone compound can prevent the progression of diabetes and control the blood glucose level, and there is no significant difference in the gains in body weight. Throughout the seven-week administration, there are no hepatic or renal toxicity observed.Type: GrantFiled: August 8, 2012Date of Patent: July 21, 2015Assignee: KAOHSIUNG MEDICAL UNIVERSITYInventors: Yang-Chang Wu, Fang-Rong Chang, Tusty-Jiuan Hsieh, Ying-Chi Du, Yi-Hong Tsai, Chi-Ting Hsieh
-
Patent number: 9060979Abstract: An antidepressant containing, as an active ingredient, at least one compound selected from a branched amino acid, a pharmaceutically acceptable salt thereof and a derivative thereof.Type: GrantFiled: October 10, 2007Date of Patent: June 23, 2015Assignee: OTSUKA PHARMACEUTICAL FACTORY, INC.Inventor: Masako Doi
-
Patent number: 9060996Abstract: Compositions and methods for providing infant nutrition with partially hydrolysed proteins and non-digestible oligosaccharides for use in induction of oral tolerance against native dietary proteins.Type: GrantFiled: June 1, 2011Date of Patent: June 23, 2015Assignee: N.V. NUTRICIAInventors: Léon Mathieu Johannes Knippels, Elisabeth Catharina Adriana Maria Van Esch, Johan Garssen
-
Patent number: 9049879Abstract: The disclosure relates to an edible energy composition that includes a methylated xanthine, a choline derivative and a flavorant.Type: GrantFiled: May 14, 2012Date of Patent: June 9, 2015Assignee: International IP Holdings LLCInventor: Manoj Bhargava
-
Patent number: 9044043Abstract: This invention relates to a balanced fat composition and use thereof in a liquid nutritional composition, in particular suitable for tube feeding. This invention further relates to said liquid nutritional composition for providing enteral nutrition to patients in need thereof, in particular for providing a complete enteral nutrition, in particular for providing a long-term enteral nutrition. More specifically, the balanced fat composition and the liquid nutritional composition comprising said balanced fat composition comprises specific amounts of linoleic acid (LA), alpha-linolenic acid (ALA), docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), at least one medium chain fatty acid (MCFA), and at least one mono-unsaturated fatty acid (MUFA). The invention relates further to a method for providing enteral nutrition to patients in need thereof comprising administering an effective amount of said liquid nutritional composition comprising the balanced fat composition according to the invention.Type: GrantFiled: December 7, 2010Date of Patent: June 2, 2015Assignee: N.V. NUTRICIAInventors: Rogier Daniël van Anholt, Zandrie Hofman, Wynette Hermina Agnes Kiers
-
Patent number: 9040075Abstract: Disclosed is a method of increasing lean body mass and reducing fat body mass in infants, said method comprising administration to an infant, term or preterm, a nutritional formula comprising a source of DHA and ARA. It has been found that the administration of DHA and ARA, or a source thereof, in infants can increase lean body mass and reduce fat body mass, when compared to an unsupplemented control formula, without impacting the total overall growth of the infant. This method is especially useful in preterm infants.Type: GrantFiled: December 17, 2004Date of Patent: May 26, 2015Assignee: ABBOTT LABORATORIESInventors: Nancy Auestad, Joan R. Jacobs
-
Patent number: 9034366Abstract: Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA either alone or in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form.Type: GrantFiled: December 17, 2013Date of Patent: May 19, 2015Assignee: U.S. Nutraceuticals, LLCInventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck
-
Publication number: 20150132359Abstract: Compositions of reducing agents and carriers for producing a stable negative oxidation reduction potential in consumable materials are disclosed and claimed. Compositions of the invention find use in enhancing the hydration and anti-oxidant value of consumable materials such as foods, beverages and cosmetics, for example. Compositions of the invention also find use in water treatment, agricultural and scientific research applications. Methods for using and making the compositions are also within the scope of the invention.Type: ApplicationFiled: September 7, 2014Publication date: May 14, 2015Inventor: DUSAN MILJKOVIC
-
Patent number: 9028814Abstract: Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA either alone or in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form.Type: GrantFiled: September 5, 2013Date of Patent: May 12, 2015Assignee: U.S. Nutraceuticals, LLCInventors: John A. Minatelli, W. Stephen Hill, Rudi E. Moerck
-
Patent number: 9028882Abstract: A nutriceutical food product includes a solid polymeric matrix and a liquid combined into a gel. The nutriceutical food product may include an immune modulator, such as transfer factor and/or a nanofraction immune modulator. A fruit component may be included in the nutriceutical food product. The fruit component may include at least one oligoproanthocyanidin-containing fruit, such as açai.Type: GrantFiled: May 5, 2009Date of Patent: May 12, 2015Assignee: 4Life Patents, LLCInventors: Brent M. Vaughan, Calvin W. McCausland, David A. Lisonbee
-
Patent number: 9023381Abstract: Pharmacologically effective amounts of a medication are delivered in pleasant tasting delivery vehicles, including gelatins and candies. Mechanisms for the reduction in surface area of noxious taste-imparting aspects of conventional medicines, and dilutive effects of positive masking elements for such medicines, especially products for inducing children to take medicines, are taught—in combination with processes and products thereby.Type: GrantFiled: October 31, 2007Date of Patent: May 5, 2015Inventor: Michelle Chow
-
Publication number: 20150118280Abstract: The present invention relates to means for protecting bioactive materials in mammalian food or feed formulations used to enhance the health status of mammals.Type: ApplicationFiled: November 3, 2014Publication date: April 30, 2015Inventors: Amir Barzilay, Hagit Koren-Lichtig
-
Patent number: 9017702Abstract: A formulation includes one or more active ingredients of poor water solubility for medical or non-medical use in the rearing of animals. The formulation is suitable for administration to the animals via their drinking water. It exhibits superior stability. The formulation comprises an active ingredient, a thickener combination and water, wherein the thickener combination comprises at least one thickener selected from the following groups A, B, C and D: (A) cellulose derivatives, such as methyl cellulose, sodium carboxy methyl cellulose, (B) non-cellulosic polysaccharide thickeners such as xanthan gums, Arabic gum, (C) cross-linked polyacrylic acid polymers, (D) hydrocolloidal hydrated silicates.Type: GrantFiled: July 6, 2011Date of Patent: April 28, 2015Assignee: KRKA, D.D., Novo MestoInventors: Denise Leskovar, Franc Vrecer, Andrejka Kramar, Ivanka Kolenc, Ivan Gobec, Helena Princ
-
Publication number: 20150104493Abstract: A consumable film adapted to adhere and to dissolve in the oral cavity that provides a local anesthetic and therapeutic agents for the treatment of oral burns or injuries. The film is designed to instantly release benzocaine, or other types of local anesthetic or therapeutic agent, upon adhesion to the affected areas of the mouth, and will continue to release sufficient quantities for pain relief and for healing over an extended period of time.Type: ApplicationFiled: December 17, 2014Publication date: April 16, 2015Inventors: Robert W. McDonald, III, Kurt Fraivillig, Adriane Shciano, Elizabeth Vansant, Lance Hansen